{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:43:39Z","timestamp":1785224619997,"version":"3.55.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,23]],"date-time":"2027-01-23T00:00:00Z","timestamp":1800662400000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DK120515"],"award-info":[{"award-number":["P30 DK120515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["T32 CA225617"],"award-info":[{"award-number":["T32 CA225617"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024219","name":"RedHill Biopharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["24-1319963-01-ESED"],"award-info":[{"award-number":["24-1319963-01-ESED"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["ICX002027A01"],"award-info":[{"award-number":["ICX002027A01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gtc.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:25:14Z","timestamp":1761654314000},"page":"55-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomarkers for Gastric Cancer and Premalignant Gastric Conditions"],"prefix":"10.1016","volume":"55","author":[{"given":"Ji Yoon","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailja C.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2018.04.026","article-title":"Endoscopic Screening in Asian Countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review","volume":"155","author":"Zhang","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5124\/jkma.2022.65.5.250","article-title":"Current status of the gastric cancer screening program in Korea","volume":"65","author":"Kim","year":"2022","journal-title":"J Korean Med Assoc"},{"key":"10.1016\/j.gtc.2025.08.001_bib4","unstructured":"Data from: cancer stat facts: surveillance, epidemiology, and end results program 2025. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/stomach\/html. Accessed July 2025."},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2024.11.001","article-title":"AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States: expert Review","volume":"168","author":"Shah","year":"2025","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","article-title":"ACG clinical guideline: diagnosis and management of gastric premalignant conditions","volume":"120","author":"Morgan","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2025.08.001_bib7","unstructured":"NCI Dictionary of Cancer Terms. National Cancer Institute. Available at: https:\/\/cancer.gov\/publications\/dictionaries\/cancer-terms\/."},{"key":"10.1016\/j.gtc.2025.08.001_bib8","unstructured":"IARC Monographs on the Identification of Carcinogenic Hazards to Humans. Lyon (France): International Agency for Research on Cancer; 1987. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK294452\/."},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.28999","article-title":"Global burden of gastric cancer attributable to Helicobacter pylori","volume":"136","author":"Plummer","year":"2015","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.gtc.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","article-title":"Global burden of oesophageal and gastric cancer by histology and subsite in 2018","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib12","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"issue":"15","key":"10.1016\/j.gtc.2025.08.001_bib13","first-page":"4737","article-title":"Gastric precancerous process in a high risk population: cohort follow-up","volume":"50","author":"Correa","year":"1990","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrgastro.2010.154","article-title":"Mechanisms of disease: Helicobacter pylori virulence factors","volume":"7","author":"Yamaoka","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/acs.jproteome.0c00466","article-title":"Helicobacter pylori immunoproteomic profiles in gastric cancer","volume":"20","author":"Song","year":"2021","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.13708","article-title":"Helicobacter pylori treatment and gastric cancer risk among individuals with high genetic risk for gastric cancer","volume":"7","author":"Xu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.001_bib17","first-page":"1138","article-title":"Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis","volume":"91","author":"Loy","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12883","article-title":"\u201cTrue\u201d Helicobacter pylori infection and non-cardia gastric cancer: a pooled analysis within the Stomach Cancer Pooling (StoP) Project","volume":"27","author":"Morais","year":"2022","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.001_bib19","first-page":"1185","article-title":"Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis","volume":"11","author":"Salomaa-Rasanen","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/CVI.00149-09","article-title":"Evaluation of Helicobacter pylori Immunoglobulin G (IgG), IgA, and IgM serologic testing compared to stool antigen testing","volume":"16","author":"She","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1083-4389.2004.00235.x","article-title":"Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review","volume":"9","author":"Gisbert","year":"2004","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3748\/wjg.v21.i4.1305","article-title":"Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis","volume":"21","author":"Ferwana","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.001_bib23","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/JCM.36.10.2803-2809.1998","article-title":"Evaluation of commercially available Helicobacter pylori serology kits: a review","volume":"36","author":"Laheij","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12671","article-title":"Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United States","volume":"25","author":"Butt","year":"2020","journal-title":"Helicobacter"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1055-9965.EPI-18-0582","article-title":"Validation of a blood biomarker for identification of individuals at high risk for gastric cancer","volume":"27","author":"Epplein","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00535-022-01933-0","article-title":"Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia","volume":"58","author":"Song","year":"2023","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000713","article-title":"Prevalence of the cagA virulence factor varies by race among Helicobacter pylori -infected patients Undergoing upper endoscopy","volume":"15","author":"Epplein","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12881","article-title":"Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: a meta-analysis","volume":"27","author":"El Hafa","year":"2022","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1593\/neo.03505","article-title":"Validity of serum pepsinogen I\/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma","volume":"6","author":"Dinis-Ribeiro","year":"2004","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.001_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142080","article-title":"Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1158\/1055-9965.EPI-21-1328","article-title":"Serum pepsinogen as a biomarker for gastric cancer in the United States: a nested case\u2013control study using the PLCO cancer screening trial data","volume":"31","author":"In","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.soi.2024.100086","article-title":"Pepsinogen and Helicobacter pylori: serum biomarkers for gastric cancer risk in a diverse United States population","volume":"1","author":"In","year":"2024","journal-title":"Surgical Oncology Insight"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cgh.2021.01.009","article-title":"Pepsinogens and gastrin demonstrate low discrimination for gastric precancerous lesions in a multi-ethnic United States cohort","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.001_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2183\/pjab.87.405","article-title":"Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - \u201cABC method\u201d","volume":"87","author":"Miki","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.21873\/anticanres.15645","article-title":"Accuracy of serum biomarker panel (GastroPanel((R))) in the diagnosis of atrophic gastritis of the corpus. Systematic review and meta-analysis","volume":"42","author":"Syrjanen","year":"2022","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001559","article-title":"Can GastroPanel be used as a triage tool to select patients with advanced atrophic gastritis for gastroscopy? A prospective clinical validation study","volume":"12","author":"Papadia","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apt.12177","article-title":"Systematic review: gastric cancer incidence in pernicious anaemia","volume":"37","author":"Vannella","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/jcm12031062","article-title":"Incidence of gastric neoplasms arising from autoimmune metaplastic atrophic gastritis: a systematic review and case reports","volume":"12","author":"Chen","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/gutjnl-2022-327827","article-title":"Autoimmune gastritis: long-term natural history in naive Helicobacter pylori-negative patients","volume":"72","author":"Rugge","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/j.gastro.2024.08.032","article-title":"Unveiling cancer-related metaplastic cells in both Helicobacter pylori infection and autoimmune gastritis","volume":"168","author":"Hoft","year":"2025","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamaoncol.2021.5395","article-title":"Association of antiparietal cell and anti-intrinsic factor antibodies with risk of gastric cancer","volume":"8","author":"Song","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-020-0187-8","article-title":"Autoimmune gastritis","volume":"6","author":"Lenti","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.gtc.2025.08.001_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211038771","article-title":"Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management","volume":"14","author":"Rustgi","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib44","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MCG.0000000000000101","article-title":"A laboratory score in the diagnosis of autoimmune atrophic gastritis: a prospective study","volume":"49","author":"Miceli","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"11\u201312","key":"10.1016\/j.gtc.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/apt.15540","article-title":"Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience","volume":"50","author":"Miceli","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib46","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review","volume":"161","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gtc.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2018-318126","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma","volume":"68","author":"Banks","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1038\/s41598-022-07947-1","article-title":"Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis","volume":"12","author":"Kishikawa","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib49","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.12.001","article-title":"AGA Institute technical review on gastric intestinal metaplasia \u2013 Part 1","volume":"158","author":"Gawron","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.ccell.2023.10.004","article-title":"Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression","volume":"41","author":"Huang","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ccell.2017.11.018","article-title":"Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer","volume":"33","author":"Huang","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41698-025-00816-w","article-title":"A spatial transcriptomic signature of 26 genes resolved at single-cell resolution characterizes high-risk gastric cancer precursors","volume":"9","author":"Huang","year":"2025","journal-title":"npj Precis Oncol"},{"issue":"13","key":"10.1016\/j.gtc.2025.08.001_bib53","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","article-title":"Helicobacter pylori, homologous-recombination genes, and gastric cancer - PubMed","volume":"388","author":"Usui","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2025.08.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104616","article-title":"Dissecting the genetic heterogeneity of gastric cancer","volume":"92","author":"Hess","year":"2023","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S1470-2045(20)30460-5","article-title":"Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study","volume":"21","author":"Jin","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers","volume":"26","author":"Mars","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib57","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4251\/wjgo.v15.i2.276","article-title":"Evaluation of polygenic risk score for risk prediction of gastric cancer","volume":"15","author":"Wang","year":"2023","journal-title":"World J Gastrointest Oncol"},{"issue":"3 Pt 1","key":"10.1016\/j.gtc.2025.08.001_bib58","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-05-2096","article-title":"High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk","volume":"12","author":"Maekita","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.001_bib59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10120-023-01399-w","article-title":"The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa","volume":"26","author":"Irie","year":"2023","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gutjnl-2014-307094","article-title":"Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study","volume":"64","author":"Asada","year":"2015","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gtc.2025.08.001_bib61","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gutjnl-2016-313387","article-title":"High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study","volume":"66","author":"Maeda","year":"2017","journal-title":"Gut"},{"issue":"7517","key":"10.1016\/j.gtc.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5009\/gnl210593","article-title":"Clinical significance of Epstein-Barr virus and Helicobacter pylori infection in gastric carcinoma","volume":"17","author":"Noh","year":"2023","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib64","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10120-021-01170-z","article-title":"Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma","volume":"24","author":"Song","year":"2021","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib65","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1938381","article-title":"The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer","volume":"10","author":"Wei","year":"2021","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/j.gastro.2011.05.040","article-title":"Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening","volume":"141","author":"Aikou","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.001_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12030695","article-title":"Serum pepsinogens combined with new biomarkers testing using chemiluminescent enzyme immunoassay for non-invasive diagnosis of atrophic gastritis: a prospective, multicenter study","volume":"12","author":"Chapelle","year":"2022","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.001_bib68","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1002\/ijc.29669","article-title":"Body iron status and gastric cancer risk in the EURGAST study","volume":"137","author":"Fonseca-Nunes","year":"2015","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.001_bib69","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41419-022-05350-2","article-title":"Liquid biopsy in gastric cancer: predictive and prognostic biomarkers","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib71","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12885-017-3738-y","article-title":"Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer","volume":"17","author":"Feng","year":"2017","journal-title":"BMC Cancer"},{"issue":"28","key":"10.1016\/j.gtc.2025.08.001_bib72","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","article-title":"MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances","volume":"43","author":"Metcalf","year":"2024","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.gtc.2025.08.001_bib73","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029242","article-title":"Clinical role of miR-421 as a novel biomarker in diagnosis of gastric cancer patients: a meta-analysis","volume":"101","author":"Xu","year":"2022","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.001_bib74","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2020-322065","article-title":"Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population","volume":"70","author":"So","year":"2021","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.001_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70790","article-title":"Novel and effective blood-based miRNA diagnostic panel for gastric cancer: a pilot study in a Japanese population","volume":"14","author":"Murano","year":"2025","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib78","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10120-021-01161-0","article-title":"A novel combination of serum microRNAs for the detection of early gastric cancer","volume":"24","author":"Abe","year":"2021","journal-title":"Gastric Cancer"},{"issue":"24","key":"10.1016\/j.gtc.2025.08.001_bib79","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.3390\/ijms21249472","article-title":"The reprimo-like gene is an epigenetic-mediated tumor suppressor and a candidate biomarker for the non-invasive detection of gastric cancer","volume":"21","author":"Alarcon","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gtc.2025.08.001_bib80","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13148-017-0413-8","article-title":"MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer","volume":"9","author":"Sandoval-Borquez","year":"2017","journal-title":"Clin Epigenet"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.001_bib81","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2023.02.044","article-title":"A liquid biopsy signature for the early detection of gastric cancer in patients - pubMed","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.001_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073333","article-title":"Methylated Reprimo Cell-Free DNA as a non-invasive biomarker for gastric cancer","volume":"26","author":"Maturana","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.001_bib83","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1055-9965.EPI-09-0250","article-title":"Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site","volume":"18","author":"Wu","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib84","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib85","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1038\/s41467-023-43562-y","article-title":"The helicobacter pylori genome project: insights into HP population structure from analysis of a worldwide collection of complete genomes","volume":"14","author":"Thorell","year":"2023","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.gtc.2025.08.001_bib86","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJMp2215609","article-title":"Why diverse clinical trial participation matters","volume":"388","author":"Schwartz","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib87","first-page":"7","article-title":"Cancer statitstics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"10.1016\/j.gtc.2025.08.001_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143501","article-title":"The PATHFINDER study: assessment of the implementation of an investigational multi-cancer early detection test into clinical practice","volume":"13","author":"Nadauld","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10409","key":"10.1016\/j.gtc.2025.08.001_bib89","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.001_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/1940-6207.CAPR-24-0107","article-title":"Multiyear clinical outcomes of cancers diagnosed following detection by a blood-based multicancer early detection test","volume":"17","author":"Buchanan","year":"2024","journal-title":"Cancer Prev Res"},{"issue":"6378","key":"10.1016\/j.gtc.2025.08.001_bib91","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.001_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11894-025-00970-y","article-title":"Multicancer Detection (MCD) testing in gastrointestinal cancers: an evolving tool for early diagnosis","volume":"27","author":"Ghosh","year":"2025","journal-title":"Curr Gastroenterol Rep"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.001_bib93","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.2917","article-title":"The US FDA\u2019s new rule for regulating laboratory-developed tests","volume":"5","author":"Aaron","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.001_bib94","first-page":"281","article-title":"[Principles and practice of mass screening for disease]","volume":"65","author":"Wilson","year":"1968","journal-title":"Boletin de la Oficina Sanitaria Panamericana Pan American Sanitary Bureau"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:00:29Z","timestamp":1773000029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855325000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0889855325000524"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2025.08.001","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for Gastric Cancer and Premalignant Gastric Conditions","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}